MedTrace Logo

Outcomes of a Trifocal IOL in Post-refractive Patients

NCT04545073 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-10-19

No results posted yet for this study

Summary

To compare the prediction error of ORA vs formula for post-LASIK cataract patients when PanOptix IOL was implanted. Using post-operative outcomes to determine if preoperative IOL calculations, including Barrett TK, Barrett Universal II, Hill RBF, ASCRS post-refractive calculator, or intraoperative aberrometry is more accurate when the two methods disagree in patients who have had previous refractive surgery undergo cataract surgery.

Conditions

  • Refractive Errors

Interventions

DEVICE

PanOptix

Trifocal IOL with ORA in post refractive patients

Sponsors & Collaborators

  • Vance Thompson Vision ND

    lead OTHER

Principal Investigators

  • Michael Greenwood, MD · Vance Thompson Vision ND

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-09
Primary Completion
2021-03-31
Completion
2021-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04545073 on ClinicalTrials.gov